Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

Evaluate the Improving Effects of Visucomplex Plus on Quality of Life in Patients With AMD

Phase: N/A Priority: Normal
NCT ID: NCT04177069 Org: User:
Start: 12/11/19 End: 12/30/20 Due: 12/30/21

Bioavailability Study of COQUN ORAL FORMULATION

Phase: N/A Priority: Normal
NCT ID: NCT03819491 Org: User:
Start: 06/22/18 End: 08/29/18 Due: 08/29/19

Evaluation of MAF-1217 in Patients With DED

Phase: N/A Priority: Normal
NCT ID: NCT03833882 Org: User:
Start: 11/27/18 End: 06/19/19 Due: 06/19/20

Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT04038034 Org: User:
Start: 09/01/19 End: 08/30/21 Due: 08/30/22

Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED

Phase: N/A Priority: Normal
NCT ID: NCT04485533 Org: User:
Start: 07/06/20 End: 04/30/21 Due: 04/30/22

VISUPRIME® Eye Drops

Phase: N/A Priority: Normal
NCT ID: NCT05677685 Org: User:
Start: 06/22/23 End: 01/23/24 Due: 01/23/25

Evaluation of the Performance of MAF-1217 on Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03833908 Org: User:
Start: 11/20/18 End: 06/17/19 Due: 06/17/20

The Usefulness of Visuprime in Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06533995 Org: User:
Start: 10/25/21 End: 02/22/22 Due: 02/22/23

Evaluation of the VisuXL® Performance on Ocular Surface Discomfort

Phase: N/A Priority: Normal
NCT ID: NCT03844737 Org: User:
Start: 10/08/18 End: 12/06/18 Due: 12/06/19